OncoSec Medical (ONCSQ)
OTHER OTC:ONCSQ
Holding ONCSQ?
Track your performance easily

OncoSec Medical (ONCSQ) Income Statement

486 Followers

OncoSec Medical Income Statement

Last quarter (Q2 2023), OncoSec Medical's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, OncoSec Medical's net income was $-6.86M. See OncoSec Medical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jul 22Jul 21Jul 20Jul 19Jul 18
Total Revenue
----$ 12.13K-
Cost of Revenue
------
Gross Profit
----$ 12.13K-
Operating Expense
$ 32.65M$ 37.01M$ 48.38M$ 43.41M$ 30.42M$ 38.57M
Operating Income
$ -32.65M$ -37.01M$ -48.38M$ -43.41M$ -30.42M$ -38.57M
Net Non Operating Interest Income Expense
$ -52.13K$ -20.93K$ -15.86K$ -5.11K$ 436.23K$ 374.05K
Other Income Expense
$ -508.85K$ -480.80K$ -960.09K$ -185.05K$ 12.84K$ 875.10K
Pretax Income
$ -32.72M$ -37.51M$ -47.58M$ -43.13M$ -30.27M$ -39.14M
Tax Provision
$ -3.33M$ -3.33M$ -2.41M$ -872.59K$ 1.30K$ 680.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -29.39M$ -34.18M$ -45.17M$ -42.25M$ -30.28M$ -39.14M
Basic EPS
$ -7.52$ -0.87$ -30.14$ -56.32--
Diluted EPS
$ -7.52$ -0.87$ -30.14$ -56.32$ -94.38$ -21.56
Basic Average Shares
$ 83.10M$ 39.30M$ 1.50M$ 751.57K$ 320.60K$ 1.82M
Diluted Average Shares
$ 83.10M$ 39.30M$ 1.50M$ 751.57K$ 320.79K$ 1.82M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -17.32M$ -37.01M$ 48.38M$ 43.41M$ 30.42M$ 38.57M
Net Income From Continuing And Discontinued Operation
$ -29.39M$ -34.18M$ -45.17M$ -42.25M$ -30.28M$ -39.14M
Normalized Income
$ -5.42M$ -40.85M$ -49.99M---
Interest Expense
------
EBIT
$ -24.46M$ -37.49M$ -47.56M$ -43.12M$ -30.27M$ -39.14M
EBITDA
$ -23.83M$ -36.43M$ -46.49M$ -42.13M$ -30.03M$ -38.80M
Currency in USD

OncoSec Medical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis